Polyclonal rabbit anti-murine plasmacytoma cell globulins induce myeloma cells apoptosis and inhibit tumour growth in mice (Q34733945)

4 August 2017

title

Polyclonal rabbit anti-murine plasmacytoma cell globulins induce myeloma cells apoptosis and inhibit tumour growth in mice (English)

1 reference

4 August 2017

1 reference

Bo Mu

1

1 reference

4 August 2017

Jin-liang Yang

2

1 reference

4 August 2017

Lan-tu Gou

3

1 reference

4 August 2017

Yu-qin Yao

4

1 reference

4 August 2017

Yan Zhou

5

1 reference

4 August 2017

Zhi-hui Cheng

6

1 reference

4 August 2017

Hua-shan Shi

7

1 reference

4 August 2017

Zhi-yong Li

8

1 reference

4 August 2017

Yuan Wen

9

1 reference

4 August 2017

Fei Leng

10

1 reference

4 August 2017

Feng-yu Cui

11

1 reference

4 August 2017

Tian-Tai Ma

12

1 reference

4 August 2017

Yu-quan Wei

13

1 reference

4 August 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21197579

21 November 2024

publication date

1 April 2011

1 reference

4 August 2017

April 2011

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21197579

full work available at URL

21 November 2024

https://link.springer.com/content/pdf/10.1007/s10495-010-0568-7.pdf

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:21197579

https://europepmc.org/articles/PMC3066393

21 November 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:21197579

https://europepmc.org/articles/PMC3066393?pdf=render

21 November 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:21197579

http://www.springerlink.com/index/pdf/10.1007/s10495-010-0568-7

21 November 2024

1 reference

10.1007/S10495-010-0568-7

DOI

https://api.crossref.org/works/10.1007/S10495-010-0568-7

21 November 2024

1 reference

4 August 2017

volume

16

1 reference

4 August 2017

issue

4

1 reference

4 August 2017

page(s)

370-381

1 reference

Monoclonal antibodies for cancer immunotherapy

4 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3066393

Cellular immunotherapy for multiple myeloma

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3066393

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3066393

Anti-CD20 monoclonal antibody therapy in multiple myeloma.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3066393

Clonogenic multiple myeloma progenitors, stem cell properties, and drug resistance

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3066393

Challenges and prospects of immunotherapy as cancer treatment.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3066393

Understanding multiple myeloma pathogenesis in the bone marrow to identify new therapeutic targets

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3066393

Immunostimulatory monoclonal antibodies for cancer therapy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3066393

Monoclonal antibodies as therapeutic agents in oncology and antibody gene therapy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3066393

Thymoglobulin targets multiple plasma cell antigens and has in vitro and in vivo activity in multiple myeloma.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3066393

Antibody production: polyclonal-derived biotherapeutics

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3066393

Multiple myeloma: monoclonal antibodies-based immunotherapeutic strategies and targeted radiotherapy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3066393

Apoptosis and complement-mediated lysis of myeloma cells by polyclonal rabbit antithymocyte globulin

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3066393

Multiple myeloma in a murine syngeneic model:modulation of growth and angiogenesis by a monoclonal antibody to kininogen

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3066393

Recombinant polyclonal antibodies for cancer therapy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3066393

Induction of HM1.24 peptide-specific cytotoxic T lymphocytes by using peripheral-blood stem-cell harvests in patients with multiple myeloma

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3066393

Human anti-CD40 antagonist antibody triggers significant antitumor activity against human multiple myeloma

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3066393

Features of extramedullary and extraosseous multiple myeloma: a report of 19 patients from a single center

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3066393

Mechanisms by which SGN-40, a humanized anti-CD40 antibody, induces cytotoxicity in human multiple myeloma cells: clinical implications

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3066393

Current therapy for multiple myeloma

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3066393

Monoclonal antibody-mediated tumor regression by induction of apoptosis.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3066393

Apoptosis. The role of the endonuclease

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3066393

Social controls on cell survival and cell death

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3066393

Apoptosis and the regulation of cell numbers in normal and neoplastic tissues: an overview

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3066393

Biased usage of BV gene families of T-cell receptors of WT1 (Wilms' tumor gene)-specific CD8 T cells in patients with myeloid malignancies.

7 July 2018

1 reference

https://api.crossref.org/works/10.1007/S10495-010-0568-7

Serum MUC‐1 as a marker of disease status in multiple myeloma patients receiving thalidomide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10495-010-0568-7

Phase II trial of subcutaneous anti-CD52 monoclonal antibody alemtuzumab (Campath-1H) as first-line treatment for patients with B-cell chronic lymphocytic leukemia (B-CLL).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10495-010-0568-7

Anti-interleukin 6 receptor antibody inhibits murine AA-amyloidosis.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3066393

CD20-Directed Serotherapy in Patients With Multiple Myeloma: Biologic Considerations and Therapeutic Applications

26 October 2018

1 reference

https://api.crossref.org/works/10.1007/S10495-010-0568-7

Complement-dependent and complement-independent cytotoxicity of polyclonal antithymocyte globulins in chronic lymphocytic leukemia

21 January 2018

1 reference

12 December 2020

Immunotherapy of cancer

1 reference

12 December 2020

Expression of CD52 on plasma cells in plasma cell proliferative disorders

1 reference

12 December 2020

Antibody against neoplastic plasma cells. I. Specific surface antigens on mouse myeloma cells

1 reference

12 December 2020

Separation of T and B lymphocytes by nylon wool columns: evaluation of efficacy by functional assays in vivo

1 reference

12 December 2020

Induction of apoptosis by quercetin: involvement of heat shock protein

1 reference

12 December 2020

Monoclonal antibody therapy of cancer

1 reference

12 December 2020

The Journal of Rheumatology

12

31

1132

M Mihara

2004

1 reference

10.1007/S10495-010-0568-7

DOI

https://api.crossref.org/works/10.1007/S10495-010-0568-7

10.1007/S10495-010-0568-7

21 November 2024

Identifiers

DOI

1 reference

4 August 2017

1 reference

4 August 2017

1 reference